Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 355

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 10
Chunk 355
---
iences, Inc. and Titan Advisory Services LLC (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 20, 2024)
  
    14.1*
    
    Code of Ethics and Business Conduct.
  
    19.1*
    
    Policy on Insider Trading.
  
    24.1*

    Power of Attorney (included on the signature page)
  
    31.1*

    Rule 13a-14(a) Certification of Principal Executive Officer
  
    31.2*
    
    Rule 13a-14(a) Certification of Principal Financial Officer
  
    32.1**
    
    Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Principal Executive Officer and Principal Financial Officer
  
    97.1*
    
    Compensation Recovery Policy.
  
    101.INS*
     
    Inline
    XBRL Instance Document
  
    101.SCH*
     
    Inline
    XBRL Taxonomy Extension Schema Document
  
    101.CAL*
     
    Inline
    XBRL Taxonomy Extension Calculation Linkbase
  
    101.DEF*
     
    Inline
    XBRL Taxonomy Extension Definition Linkbase
  
    101.LAB*
     
    Inline
    XBRL Taxonomy Extension Labels Linkbase
  
    101.PRE*
     
    Inline
    XBRL Taxonomy Extension Presentation Linkbase
  
    104*
     
    Cover
    Page Interactive Data File (embedded within the Inline XBRL document)

*
Filed herewith.

**
Furnished herewith.

†
Management contracts, compensation plans and arrangements.

Item
16. Form 10-K Summary

Not
applicable.

124

JUPITER
NEUROSCIENCES, INC.

Index
to Financial Statements

    Report
    of Independent Registered Public Accounting Firm Assurance Dimensions, LLC PCAOB ID: 5036
    F-2

    Balance Sheets as of December 31, 2024 and 2023
    F-3

    Statements of Operations for the Years Ended December 31, 2024 and 2023
    F-4

    Statements
    of Changes in Stockholders’ Equity (Deficit) for the Years Ended December 31, 2024 and 2023
    F